Inspire Medical Systems Inc(INSP) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 5:05 PM ET (Korea 10/31 06:05)
Full metrics table
| Index | RUT | P/E | 14.79 | EPS (ttm) | 4.6 | Insider Own | 5.72% | Shs Outstand | 28.9M | Perf Week | -4.23% |
| Market Cap | 1.97B | Forward P/E | 46.22 | EPS next Y | 18.91% | Insider Trans | -0.3% | Shs Float | 27.3M | Perf Month | -3.79% |
| Enterprise Value | 1.68B | PEG | - | EPS next Q | 0.09 | Inst Own | 123.03% | Short Float | 16.48% | Perf Quarter | 30.41% |
| Income | 0.14B | P/S | 2.19 | EPS this Y | -48.8% | Inst Trans | -6.31% | Short Ratio | 5.82 | Perf Half Y | 20.11% |
| Sales | 0.90B | P/B | 2.38 | EPS next 5Y | -7.61% | ROA | 15.63% | Short Interest | 4.49M | Perf YTD | -26.16% |
| Book/sh | 28.56 | P/C | 6.14 | EPS past 3/5Y | - | ROE | 17.96% | 52W High | -53.68% ($147.03) | Perf Year | -6.8% |
| Cash/sh | 11.09 | P/FCF | 16.81 | Sales past 3/5Y | 30.77% 51.21% | ROIC | 15.8% | 52W Low | 75.02% ($38.91) | Perf 3Y | -53.3% |
| Dividend Est. | - | EV/EBITDA | 23.51 | EPS Y/Y TTM | 161.83% | Gross Margin | 86.13% | Volatility(W/M) | 3.24% 3.76% | Perf 5Y | -74.74% |
| Dividend TTM | - | EV/Sales | 1.87 | Sales Y/Y TTM | 4.35% | Oper. Margin | 6.02% | ATR (14) | 2.77 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.16 | EPS Q/Q | 108.87% | Profit Margin | 15.03% | RSI (14) | 45.35 | Recom | 2.89 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.55 | Sales Q/Q | -7.6% | SMA20 | -2.59% ($69.91) | Beta | 0.67 | Target Price | $68 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/11/2 | SMA50 | -0.72% ($68.59) | Rel Volume | 1.03 | Prev Close | $71.18 |
| Employees | 1333 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 159.35% 3.01% | SMA200 | 16.26% ($58.58) | Avg Volume(3M) | 0.77M | Price | $68.1 |
| IPO | 2018/5/3 | Option/Short | Yes/Yes | Trades | 6843 | Volume | 796,443 | Change | -4.33% |
😴 Inspire Medical Systems (INSP) is a U.S. medical device company that develops and sells minimally invasive neurostimulation therapy systems for patients with obstructive sleep apnea. Its implantable "Inspire therapy" stimulates the hypoglossal nerve to keep the airway open and has established itself as an alternative for moderate-to-severe patients who cannot tolerate conventional CPAP machines, building a distinct treatment category within the sleep apnea market.
Over the past 1 year, roughly in the middle
54% below its 1-year high.
Traded about as much as usual. That is 103% of its average volume.
Next earnings report: November 2
That is today.
INSP makes money exceptionally well
Of every $100 in sales, $6.02 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -48.8% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $2,351. Peers typically go for $1,316. Compared with its own 2-year average, it is 75% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -74.7%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 123.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #29 of 142 in the industry
Based on market cap of $2B.
UFPT#27 UFP Technologies Inc $2B PER 30.7 
ALMR#28 Alamar Biosciences Inc $2B PER - INSP#29 Inspire Medical Systems Inc $2B PER 14.8 
ESTA#30 Establishment Labs Holdings Inc $2B PER - 
BFLY#31 Butterfly Network Inc $2B PER - 
FAQ
What kind of company is INSP?
INSP belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of INSP?
The market cap of INSP is approximately $2.0B, ranking 2,051 within its sector.
What is the P/E ratio of INSP?
INSP has a P/E ratio of approximately 14.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for INSP?
INSP has recorded a 52-week high of $147.03 and a low of $38.91.
